Gaelle M. Lefevrewill highlight how our next generationAAV vectorsderived from our proprietary ALIGATER (AAV-Ligand Conjugate) platform have higher potency thanstandardAAV vectors with improved biodistribution and transduction in neural tissues.
Abstract title:Chemical engineering of AAV capsids improves their biodistribution and transduction properties in neural tissues
The abstract which Gaelle M. Lefevre will present tomorrow 12 October at the 29th European Society of Gene and Cell Therapy Congress is now available to view for registered attendees online / via the ESCGT app. The poster, #P019, is available for viewing in the poster hall.